Myriad Genetics
MYGN
MYGN
201 hedge funds and large institutions have $518M invested in Myriad Genetics in 2026 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 75 increasing their positions, 68 reducing their positions, and 48 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
9% less funds holding
Funds holding: 221 → 201 (-20)
35% less first-time investments, than exits
New positions opened: 31 | Existing positions closed: 48
Holders
201
Holding in Top 10
–
Calls
$97K
Puts
$83K
Top Buyers
| 1 | +$6.89M | |
| 2 | +$6.86M | |
| 3 | +$5.98M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$5.63M |
| 5 |
GCM
Glenview Capital Management
New York
|
+$4.3M |
Top Sellers
| 1 | -$33.4M | |
| 2 | -$8.04M | |
| 3 | -$4.16M | |
| 4 |
RA
Royce & Associates
New York
|
-$3.72M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
-$2.86M |
